File this under “not ready for prime time.”
The US Food and Drug Administration scolded two drug makers for using loud music and fast-paced visuals in their television ads that obscured important risk information.
Unlock this article by subscribing to STAT Plus. To get you started, enjoy 50% off your first 3 months!
GET STARTEDWhat is it?
STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.
What's included?
- Daily reporting and analysis
- The most comprehensive industry coverage from a powerhouse team of reporters
- Subscriber-only newsletters
- Daily newsletters to brief you on the most important industry news of the day
- Online intelligence briefings
- Frequent opportunities to engage with veteran beat reporters and industry experts
- Exclusive industry events
- Premium access to subscriber-only networking events around the country
- The best reporters in the industry
- The most trusted and well-connected newsroom in the health care industry
- And much more
- Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
About the Author
The only honest part about these Type 2 diabetes ads is that they feature the heftyweights who got the condition because they couldn’t stay off the carbo line at Dunkin Donuts, KFC, or Bob’s Big Boy.
Wrong music. Celgene should mellow us out with “I’ve got you under my skin”.
Nice try, but in my opinion the soundtrack since 9/11 is “World of confusion”….